We are live on ! Find out more
Northern Trust

Northern Trust Portfolio holdings

AUM $757B
1-Year Est. Return 28.64%
 

Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.

This Fund
S&P 500
This Quarter Est. Return
-12.77%
1 Year Est. Return
+28.64%
3 Year Est. Return
+94.48%
5 Year Est. Return
+125.76%
10 Year Est. Return
+523.41%
AUM
$357B
AUM Growth
-$52.1B
Cap. Flow
+$7.49B
Cap. Flow %
2.1%
Top 10 Hldgs %
15.53%
Holding
4,401
New
95
Increased
1,835
Reduced
2,070
Closed
125

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$994M
2
CI icon
Cigna
CI
+$524M
3
MSFT icon
Microsoft
MSFT
+$395M
4
AMZN icon
Amazon
AMZN
+$281M
5
CVS icon
CVS Health
CVS
+$265M

Sector Composition

Rank Sector Weight
1 Technology 15.98%
2 Financials 14.41%
3 Healthcare 13.78%
4 Consumer Discretionary 9.86%
5 Industrials 8.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRSP icon
3501
CRISPR Therapeutics
CRSP
$5.17B
$634K ﹤0.01%
22,207
-6,110
-22% -$212K
TESS
3502
DELISTED
Tessco Technologies Inc
TESS
$633K ﹤0.01%
52,843
-10,019
-16% -$124K
TGS icon
3503
Transportadora de Gas del Sur
TGS
$4.41B
$632K ﹤0.01%
43,738
+8,288
+23% +$118K
NCSM icon
3504
NCS Multistage Holdings
NCSM
$132M
$624K ﹤0.01%
6,137
-30
-0.5% -$5.76K
SSRM icon
3505
SSR Mining
SSRM
$6.4B
$623K ﹤0.01%
51,552
-1,047
-2% -$11.1K
JNCE
3506
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$619K ﹤0.01%
183,824
-1,855
-1% -$8.67K
EIGR
3507
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$617K ﹤0.01%
2,025
+447
+28% +$144K
RVLP
3508
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$615K ﹤0.01%
+79,462
New +$636K
IEUR icon
3509
iShares Core MSCI Europe ETF
IEUR
$9.14B
$613K ﹤0.01%
14,841
-302
-2% -$13.3K
KODK icon
3510
Kodak
KODK
$978M
$612K ﹤0.01%
240,383
-1,524
-0.6% -$4.64K
VAW icon
3511
Vanguard Materials ETF
VAW
$3.1B
$606K ﹤0.01%
5,468
OPNT
3512
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$604K ﹤0.01%
41,803
+1,398
+3% +$22.8K
CLCT
3513
DELISTED
Collectors Universe
CLCT
$603K ﹤0.01%
53,062
-1,218
-2% -$16.4K
BLFS icon
3514
BioLife Solutions
BLFS
$1.69B
$598K ﹤0.01%
49,729
+8,003
+19% +$95.6K
SPRO icon
3515
Spero Therapeutics
SPRO
$71.2M
$595K ﹤0.01%
96,833
+1,038
+1% +$8.41K
AGNT
3516
AGNT Inc
AGNT
$715M
$591K ﹤0.01%
+167,014
New +$938K
MTUM icon
3517
iShares MSCI USA Momentum Factor ETF
MTUM
$25.4B
$588K ﹤0.01%
+5,866
New +$628K
ALOT icon
3518
AstroNova
ALOT
$226M
$587K ﹤0.01%
31,297
-1,407
-4% -$27.4K
STRO icon
3519
Sutro Biopharma
STRO
$423M
$580K ﹤0.01%
+6,432
New +$776K
ORTX
3520
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$579K ﹤0.01%
+3,681
New +$549K
BBAR icon
3521
BBVA Argentina
BBAR
$3.53B
$572K ﹤0.01%
50,522
+10,361
+26% +$117K
RNAC icon
3522
Cartesian Therapeutics
RNAC
$265M
$572K ﹤0.01%
7,154
+7
+0.1% +$1.6K
STR
3523
DELISTED
Sitio Royalties
STR
$572K ﹤0.01%
+16,822
New +$599K
LOMA
3524
Loma Negra
LOMA
$1.21B
$569K ﹤0.01%
51,104
-1,045
-2% -$10.1K
MRSN
3525
DELISTED
Mersana Therapeutics
MRSN
$567K ﹤0.01%
5,565
-276
-5% -$43.7K

Similar funds

Northern Trust's Q4 2018 Portfolio in Review

As of Q4 2018, Northern Trust held 4,401 positions worth $357B, down 13% from $409B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2018: portfolio turnover was 5%. Northern Trust opened 95 new positions and exited 125, leaving the 4,401-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Northern Trust's largest Q4 2018 buy was Linde: 6,288,266 shares worth $981M.
  • Northern Trust added most to Cigna in Q4 2018, an estimated $524M increase.
  • Northern Trust's biggest Q4 2018 reduction was FlexShares iBoxx 3-Year Target Duration TIPS Index Fund, cutting an estimated $224M.
  • Northern Trust fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $918M.
  • Northern Trust's ten largest holdings make up 16% of its $357B portfolio in Q4 2018.
  • Northern Trust opened 95 new positions and closed 125 in Q4 2018.
  • Northern Trust's portfolio value fell 13% quarter-over-quarter to $357B.

Based on Northern Trust's 13F filing for Q4 2018, filed 12 Feb 2019.